Ipo Lisboa

Lisbon 1500-650

0 studies enrolling now · 5 studies all time

What they study most

Cancer, Head and Neck Cancer, Metastatic Breast Cancer, Prostatic Neoplasms, Squamous Cell Cancer, Venous Thromboembolism

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer — Running, not enrolling
• Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype — Stopped early
• Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer — Completed
• Zalutumumab in Non-curable Patients With SCCHN — Completed